Unichem Lab gets USFDA nod for chronic angina drug 0 17.03.2023 10:51 Business Standard Unichem Laboratories announced that it has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for its Ranolazine extended-release tablets. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
